Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05622058
Title A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BGR

Facility Status City State Zip Country Details
Oncology and Hematology Associates of West Broward Tamarac Florida 33321 United States Details
Southern Oncology Specialists Huntersville North Carolina 28078 United States Details
Regional Medical Oncolgy Center Wilson North Carolina 27893 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Pennsylvania Cancer Specialists & Resesrach Institute Gettysburg Pennsylvania 17325 United States Details
University Clinical Center of the Republic of Srpska Banja Luka 71000 Bosnia and Herzegovina Details
University Clinical Hospital Mostar Mostar 88000 Bosnia and Herzegovina Details
Clinical Center University of Sarajevo, Oncology Clinic Sarajevo 71000 Bosnia and Herzegovina Details
University Clinical Center Tuzla Tuzla 75000 Bosnia and Herzegovina Details
MBAL University Hospital OOD Panagyurishte 4500 Bulgaria Details
KOC (Complex Oncology Center) Plovdiv Plovdiv 4000 Bulgaria Details
Kliničko bolnički centar "Bežanijska kosa" Belgrade 11070 Serbia Details
Univerzitetski Klinički centar Kragujevac Kragujevac 34000 Serbia Details
Oncology Institute of Vojvodina Sremska Kamenica 21204 Serbia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field